价格

GRIFOLS BIOLOGICALS LLC

630 Malvern Ave, Hot Springs National Park, Arkansas, 美国

别名:

alpha therapeutic corp #423

alpha plasma center

alpha plasma center #437

alpha plasma center #418

alpha plasma center #436

alpha therapeutic

概览

试验阶段分布

阶段

试验数

占比

3 期

42.9%

2 期

28.6%

4 期

28.6%

试验状态分布

进行中（未招募）

28.6%

已完成

57.1%

招募中

14.3%

药物批准

按机构分类的批准

NMPA

National Medical Products Administration

药物批准

CANADA

Health Canada

药物批准

PHILIPPINES

Philippines FDA

药物批准

SFDA

Saudi Food and Drug Authority

药物批准

NPRA

National Pharmaceutical Regulatory Agency

药物批准

近期批准

ALPHANATE 1000 IU INJECTION

NPRA

2025-11-28

ALPHANINE INJECTION SD 500 IU

NPRA

2025-11-28

INJECTION ALPHANINE SD 1000 IU

NPRA

2025-11-28

Albumin (Human) U.S.P., Albutein� 20%, Solution for Infusion

NPRA

2025-11-28

ALBUTEIN 5%,ALBUMIN (HUMAN)-250ML

NPRA

2025-11-28

ALBUTEIN 25%,ALBUMIN (HUMAN)-50ML

NPRA

2025-11-28

ALPHANATE 250 IU INJECTION

NPRA

2025-11-28

ALPHANATE 500 IU INJECTION

NPRA

2025-11-28

ALBUTEIN 25%,ALBUMIN (HUMAN) 100ML

NPRA

2025-11-28

ALBUTEIN 5%,ALBUMIN (HUMAN)-500ML

NPRA

2025-11-28

资讯

暂无资讯文章

返回机构列表

GRIFOLS BIOLOGICALS LLC

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（7）

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries

IGIV Study for Chronic ITP Patients Ages 3-70

Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients

Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate

Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

药物批准

按机构分类的批准

近期批准

资讯